AR072389A1 - Compuesto de 3-cianopirrolidinil-fenil-oxazolidinona, procedimiento para prepararlo, composicion farmaceutica que la comprende y sus usos - Google Patents

Compuesto de 3-cianopirrolidinil-fenil-oxazolidinona, procedimiento para prepararlo, composicion farmaceutica que la comprende y sus usos

Info

Publication number
AR072389A1
AR072389A1 ARP090102398A ARP090102398A AR072389A1 AR 072389 A1 AR072389 A1 AR 072389A1 AR P090102398 A ARP090102398 A AR P090102398A AR P090102398 A ARP090102398 A AR P090102398A AR 072389 A1 AR072389 A1 AR 072389A1
Authority
AR
Argentina
Prior art keywords
oxazolidinona
cyanopirrolidinil
fenil
prepare
composite
Prior art date
Application number
ARP090102398A
Other languages
English (en)
Inventor
Biosca Montserrat Cano
Antonio Guglietta
Benet Albert Palomer
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40010598&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR072389(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of AR072389A1 publication Critical patent/AR072389A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/08Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

También se proporcionan procedimientos de preparacion, composiciones farmacéuticas y usos de los mismos para el tratamiento de infecciones bacterianas. Reivindicacion 1: Un compuesto de 3-cianopirrolidinil-fenil oxazolidinona, caracterizado porque es de formula (1), en forma libre o en forma de una sal farmacéuticamente aceptable, solvato, hidrato, o una forma enantiomérica, donde: R1 y R2 son radicales idénticos o diferentes y se seleccionan independientemente entre hidrogeno y fluor; R3 es un grupo alquilo C1-6 lineal o ramificado opcionalmente sustituido por un grupo seleccionado entre fluor, hidroxi y OR4; y R4 es un grupo alquilo C1-6 lineal o ramificado.
ARP090102398A 2008-07-01 2009-06-29 Compuesto de 3-cianopirrolidinil-fenil-oxazolidinona, procedimiento para prepararlo, composicion farmaceutica que la comprende y sus usos AR072389A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08159446A EP2141161A1 (en) 2008-07-01 2008-07-01 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents

Publications (1)

Publication Number Publication Date
AR072389A1 true AR072389A1 (es) 2010-08-25

Family

ID=40010598

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090102398A AR072389A1 (es) 2008-07-01 2009-06-29 Compuesto de 3-cianopirrolidinil-fenil-oxazolidinona, procedimiento para prepararlo, composicion farmaceutica que la comprende y sus usos

Country Status (23)

Country Link
US (1) US20110152333A1 (es)
EP (2) EP2141161A1 (es)
JP (1) JP2011526589A (es)
KR (1) KR20110036601A (es)
CN (1) CN102112471A (es)
AR (1) AR072389A1 (es)
AT (1) ATE541842T1 (es)
AU (1) AU2009265790A1 (es)
BR (1) BRPI0913842A2 (es)
CA (1) CA2729491A1 (es)
CL (2) CL2009001493A1 (es)
CY (1) CY1112684T1 (es)
DK (1) DK2321306T3 (es)
ES (1) ES2381155T3 (es)
MX (1) MX2011000141A (es)
PE (1) PE20110161A1 (es)
PL (1) PL2321306T3 (es)
PT (1) PT2321306E (es)
RU (1) RU2011103485A (es)
SI (1) SI2321306T1 (es)
TW (1) TW201006828A (es)
UY (1) UY31953A (es)
WO (1) WO2010000703A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101128029B1 (ko) 2010-03-08 2012-03-29 주식회사 레고켐 바이오사이언스 (r)-3-(3-플루오로-4-(1-메틸-5,6-다이하이드로-1,2,4-트리아진-4(1h)-일)페닐)-5-(치환된 메틸)옥사졸리딘-2-온 유도체의 제조방법
US9573910B2 (en) * 2013-11-08 2017-02-21 Lee Pharma Limited Oxazolidinone antibacterial compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
EP0788498B1 (en) * 1994-10-26 2001-08-16 PHARMACIA & UPJOHN COMPANY Phenyloxazolidinone antimicrobials
US7687627B2 (en) * 2003-09-08 2010-03-30 Wockhardt Limited Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy

Also Published As

Publication number Publication date
JP2011526589A (ja) 2011-10-13
EP2141161A1 (en) 2010-01-06
UY31953A (es) 2010-01-29
RU2011103485A (ru) 2012-08-10
MX2011000141A (es) 2011-04-05
ATE541842T1 (de) 2012-02-15
ES2381155T3 (es) 2012-05-23
BRPI0913842A2 (pt) 2015-10-20
PL2321306T3 (pl) 2012-06-29
CL2009001493A1 (es) 2009-12-11
DK2321306T3 (da) 2012-04-10
EP2321306A1 (en) 2011-05-18
US20110152333A1 (en) 2011-06-23
EP2321306B1 (en) 2012-01-18
CN102112471A (zh) 2011-06-29
PT2321306E (pt) 2012-04-13
CA2729491A1 (en) 2010-01-07
AU2009265790A1 (en) 2010-01-07
SI2321306T1 (sl) 2012-05-31
WO2010000703A1 (en) 2010-01-07
CL2010001589A1 (es) 2011-11-11
TW201006828A (en) 2010-02-16
CY1112684T1 (el) 2016-02-10
PE20110161A1 (es) 2011-03-15
KR20110036601A (ko) 2011-04-07

Similar Documents

Publication Publication Date Title
ES2477940T3 (es) Imidazoles condensados y composiciones que los incluyen para el tratamiento de enfermedades parasitarias tales como por ejemplo malaria
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
CO6470846A2 (es) Derivados aminobut´ricos sustituidos como inhibidores de neprilisina
CL2012001911A1 (es) Compuestos derivados de fumarato; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad inflamatoria o neurodegenerativa.
CO6620055A2 (es) Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos
CL2012000999A1 (es) Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina.
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
BR112013011580A2 (pt) derivados de ácido bisfenil pentanoico substituído por amino como inibidores de nep
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
PE20201256A1 (es) Compuestos monobactamicos cromanos para el tratamiento de infecciones bacterianas
BR112015001502A2 (pt) derivados de tipo azaindazol ou diazaindazol para tratamento de dor
AR079050A1 (es) Compuestos benzoimidazolicos y sus usos
CR10479A (es) Modulares bencimidazolicos de vr1
CU23761B7 (es) Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
AR062737A1 (es) Composicion farmaceutica que comprende un compuesto derivado de aril-azabiciclo, compuesto correspondiente y su uso para la preparacion de un medicamento
AR087470A1 (es) Derivados imidazolicos bifenilenicos y composiciones farmaceuticas que los contienen
AR076263A1 (es) Composiciones y metodos para tratar cancer. uso.
AR078722A1 (es) Derivados de 2-oxo-1-pirrolidinila imidazotiadiazol
BR112018069712A2 (pt) composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, método para administração de uma quantidade eficaz de uma composição farmacêutica, e, inibidor de tnf-a.
EA201391524A1 (ru) Производные гликозида и их применение
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos
AR074593A1 (es) Benzotiazol amidas para la deteccion del peptido beta amiloide
AR077662A1 (es) Compuestos de 3- fenoximetilpirrolidina
PE20100154A1 (es) Pregn-4-en-21,17-carbolactonas sustituidas en el anillo c, asi como preparados farmaceuticos que las contienen
UY32316A (es) Derivados de piperidina utiles en el tratamiento de infecciones bacterianas

Legal Events

Date Code Title Description
FB Suspension of granting procedure